Technology

cath lab stents drug eluting boston scientific promus premier

December 2, 2013 — Boston Scientific Corporation has received U.S....

Medtronic Resolute Integrity Stent FDA Approval 34, 38 mm

The 34 and 38 mm lengths of the Medtronic Resolute Integrity drug-eluting stent in diameters of 3, 3.5 and 4 mm with an indication for patients with diabetes are available to cardiac catheterizatio...

Cook, Zilver PTX, stent, expanding, delivery sheath

Cook Medical’s Zilver PTX drug-eluting peripheral stent is the first device of its kind on several fronts to go before FDA review....

The 32 and 38 mm lengths of Boston Scientific's Promus Element Plus everolimus-eluting platinum chromium (PtCr) coronary stent system, the company's next-generation

The Promus Element Plus everolimus-eluting platinum chromium coronary stent system is Boston Scientific's next-generation drug-eluting stent (DES) technology.  It is designed to provide physic...

The Xience Prime everolimus-eluting coronary stent system for the treatment of coronary artery disease uses the same drug and biocompatible polymer as the Xience V, but features an enhanced stent d...

Johnson & Johnson subsidiary Cordis International announced in June 2011 it will cease production of the Cypher sirolimus-eluting stent, the first drug-eluting stent (DES) by the end of 2011....
Boston Scientific released its 2.25 mm Promus everolimus-eluting coronary stent system for use in vessels as small as 2.25 mm in diameter....
The Xience nano everolimus-eluting coronary stent system is designed to treat coronary artery disease in vessels as small as 2.25 mm in diameter....

Boston Scientific’s thrid-generation drug-eluting stent, the Ion paclitaxel-eluting coronary stent system, features a platinum chromium (PtCr) alloy designed specifically for coronary stenting and ...

Cordis Corp. offers the 2.25 mm CYPHER Sirolimus-Eluting Coronary Stent, which is indicated for treatment of coronary blockages in small vessels.

...

Boston Scientific's TAXUS Liberte Long Paclitaxel-Eluting Coronary Stent System is designed for long lesions....

Boston Scientific's TAXUS Liberte Atom Paclitaxel-Eluting Coronary Stent System is a next-generation drug-eluting stent (DES) specifically designed for treating small coronary vessels....

The CYPHER Sirolimus-eluting Coronary Stent offered by Cordis (a Johnson & Johnson company) was the first drug-eluting stent approved for the U.S. market when it was approved by the FDA in 2003.

...

The Endeavor Sprint drug-eluting stent (DES) is now offered on a rapid exchange (RX) delivery system.
...

The FDA recently cleared Boston Scientific Corp.’s PROMUS Everolimus-Eluting Coronary Stent System.

...

The FDA recently cleared Boston Scientific Corp.’s PROMUS Everolimus-Eluting Coronary Stent System and Abbott Vascular’s XIENCE V Everolimus Eluting Coronary Stent System, both for the treatment of co...

Medtronic Inc. recently announced the initiation of the first investigational sites in the U.S....

OrbusNeich will showcase its Genous Stent at TCT 2008, a stent that was CE Marked in 2005....